182
Participants
Start Date
July 30, 2021
Primary Completion Date
August 25, 2023
Study Completion Date
May 31, 2025
EFX
Investigational drug, Efruxifermin
Placebo
Placebo
Akero Clinical Study Site, Richmond
Akero Clinical Study Site, Concord
Akero Clinical Study Site, Fayetteville
Akero Clinical Study Site, Morehead City
Akero Clinical Study Site, Summerville
Akero Clinical Study Site, Greenville
Akero Clinical Study Site, Greenwood
Akero Clinical Study Site, Hialeah Gardens
Akero Clinical Study Site, Miami Lakes
Akero Clinical Study Site, Clearwater
Akero Clinical Study Site, Fort Myers
Akero Clinical Study Site, Fort Myers
Akero Clinical Study Site, Lakewood Rch
Akero Clinical Study Site, Sarasota
Akero Clinical Study Site, Ocala
Akero Clinical Study Site, Nashville
Akero Clinical Study Site, Westlake
Akero Clinical Study Site, Springboro
Akero Clinical Study Site, South Bend
Akero Clinical Study Site, Topeka
Akero Clinical Study Site, Marrero
Akero Clinical Study Site, Bastrop
Akero Clinical Study Site, North Little Rock
Akero Clinical Study Site, Fort Worth
Akero Clinical Study Site, Dallas
Akero Clinical Study Site, Fort Worth
Akero Clinical Study Site, Wichita Falls
Akero Clinical Study Site, Waco
Akero Clinical Study Site, Houston
Akero Clinical Study Site, Houston
Akero Clinical Study Site, Webster
Akero Clinical Study Site, San Antonio
Akero Clinical Study Site, Edinburg
Akero Clinical Study Site, Edinburg
Akero Clinical Study Site, Austin
Akero Clinical Study Site, Englewood
Akero Clinical Study Site, Ogden
Akero Clinical Study Site, Chandler
Akero Clinical Study Site, Glendale
Akero Clinical Study Site, Tucson
Akero Clinical Study Site, Tucson
Akero Clinical Study Site, Las Vegas
Akero Clinical Study Site, Los Angeles
Akero Clinical Study Site, Long Beach
Akero Clinical Study Site, Pasadena
Akero Clinical Study Site, Fresno
Akero Clinical Study Site, Mexico City
Akero Clinical Study Site, Monterrey
Akero Clinical Study Site, San Juan
Lead Sponsor
Akero Therapeutics, Inc
INDUSTRY